Experimental breast cancer drug holds promise in combination therapy for Ewing sarcoma

St. Jude Children's Research Hospital researchers have identified a promising new triple-drug combination therapy that exploits DNA repair problem in Ewing sarcoma tumors; clinical trials expected to open soon. Ewing sarcoma tumors disappeared and did not return in more than 70 percent of mice treated with combination therapy that included drugs from a family of experimental agents developed to fight breast cancer, reported St. Jude Children's Research Hospital scientists. The study will appear in the November 6 edition of the scientific journal Cell Reports.

Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...